416 related articles for article (PubMed ID: 33104947)
61. Beyond medications: office-based procedures for benign prostatic obstruction.
Tran PU; Chung ASJ
World J Urol; 2019 Jun; 37(6):1023-1027. PubMed ID: 31037402
[TBL] [Abstract][Full Text] [Related]
62. How can we Preserve Sexual Function after Ablative Surgery for Benign Prostatic Hyperplasia?
Mykoniatis I; Renterghem KV; Sokolakis I
Curr Drug Targets; 2021; 22(1):4-13. PubMed ID: 32981500
[TBL] [Abstract][Full Text] [Related]
63. [Sexual consequences of BPH treatments].
Descazeaud A; Robert G; de La Taille A
Prog Urol; 2018 Nov; 28(15):839-847. PubMed ID: 30195716
[TBL] [Abstract][Full Text] [Related]
64. Review of Sexual Preservation After Novel Benign Prostatic Hyperplasia Surgical Treatment Modalities From Food and Drug Administration Clinical Trials.
Bhojani N; Yafi FA; Misrai V; Rijo E; Chughtai B; Zorn KC; Elterman D
Sex Med Rev; 2021 Jan; 9(1):169-173. PubMed ID: 33309271
[TBL] [Abstract][Full Text] [Related]
65. New Ultra-minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia: A Systematic Review and Analysis of Comparative Outcomes.
Checcucci E; Veccia A; De Cillis S; Piramide F; Volpi G; Amparore D; Pecoraro A; Piana A; Granato S; Verri P; Sica M; Meziere J; Carbonaro B; Piscitello S; Zamengo D; Cacciamani G; Okhunov Z; Puliatti S; Taratkin M; Marenco J; Gomez Rivas J; Veneziano D; Carbonara U; Russo GI; De Luca S; Manfredi M; Fiori C; Autorino R; Porpiglia F;
Eur Urol Open Sci; 2021 Nov; 33():28-41. PubMed ID: 34604814
[TBL] [Abstract][Full Text] [Related]
66. New Endoscopic In-office Surgical Therapies for Benign Prostatic Hyperplasia: A Systematic Review.
Tzeng M; Basourakos SP; Lewicki PJ; Hu JC; Lee RK
Eur Urol Focus; 2022 Mar; 8(2):522-531. PubMed ID: 33663982
[TBL] [Abstract][Full Text] [Related]
67. Benign Prostatic Hyperplasia: Clinical Manifestations, Imaging, and Patient Selection for Prostate Artery Embolization.
Powell T; Kellner D; Ayyagari R
Tech Vasc Interv Radiol; 2020 Sep; 23(3):100688. PubMed ID: 33308530
[TBL] [Abstract][Full Text] [Related]
68. Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis.
Wang XY; Zong HT; Zhang Y
Clin Interv Aging; 2016; 11():1609-1622. PubMed ID: 27956827
[TBL] [Abstract][Full Text] [Related]
69. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
McVary KT; Gange SN; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Rousseau M; Beahrs JR; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Larson TR; Dixon CM; Roehrborn CG
J Urol; 2016 May; 195(5):1529-1538. PubMed ID: 26614889
[TBL] [Abstract][Full Text] [Related]
70. [Minimally-Invasive Surgical Techniques (MIST): Shedding Light on the Mist].
Netsch C; Gross AJ; Herrmann TR; Herrmann J; Becker B
Aktuelle Urol; 2024 Jun; 55(3):219-227. PubMed ID: 38547919
[TBL] [Abstract][Full Text] [Related]
71. Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications.
Seftel A; Rosen R; Kuritzky L
Int J Impot Res; 2007; 19(4):386-92. PubMed ID: 17377613
[TBL] [Abstract][Full Text] [Related]
72. Minimally Invasive Treatments for Benign Prostatic Hyperplasia: Systematic Review and Network Meta-Analysis.
Sajan A; Mehta T; Desai P; Isaacson A; Bagla S
J Vasc Interv Radiol; 2022 Apr; 33(4):359-367.e8. PubMed ID: 34968671
[TBL] [Abstract][Full Text] [Related]
73. Prostatic hydroablation (Aquablation): A new effective ultrasound guided robotic waterjet ablative surgery for treatment of benign prostatic hyperplasia.
Lim Ng K; Barber N
Arch Esp Urol; 2019 Oct; 72(8):786-793. PubMed ID: 31579037
[TBL] [Abstract][Full Text] [Related]
74. Mini-Review: What Is New in Urolift?
Magistro G; Stief CG; Woo HH
Eur Urol Focus; 2018 Jan; 4(1):36-39. PubMed ID: 29475817
[TBL] [Abstract][Full Text] [Related]
75. Prostatic Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Call for Universal Adoption of Ejaculatory Function Reporting.
Roberts DG; Callese TE; Okafor E; Naik P; Harrison B; Tse G; Plotnik AN; McWilliams JP
J Vasc Interv Radiol; 2020 Dec; 31(12):2153-2156. PubMed ID: 33139187
[No Abstract] [Full Text] [Related]
76. Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry.
Rosen RC; Wei JT; Althof SE; Seftel AD; Miner M; Perelman MA;
Urology; 2009 Mar; 73(3):562-6. PubMed ID: 19167031
[TBL] [Abstract][Full Text] [Related]
77. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.
Lowe FC
BJU Int; 2005 Jun; 95 Suppl 4():12-8. PubMed ID: 15871731
[TBL] [Abstract][Full Text] [Related]
78. Aquablation, Prostatic Urethral Lift, and Transurethral Water Vapor Therapy: A Comparison of Device-Related Adverse Events in a National Registry.
Kaplan-Marans E; Martinez M; Wood A; Cochran J; Dubowitch E; Schulman A
J Endourol; 2022 Feb; 36(2):231-235. PubMed ID: 34314240
[No Abstract] [Full Text] [Related]
79. Sexual outcome of patients undergoing thulium laser enucleation of the prostate for benign prostatic hyperplasia.
Carmignani L; Bozzini G; Macchi A; Maruccia S; Picozzi S; Casellato S
Asian J Androl; 2015; 17(5):802-6. PubMed ID: 25652616
[TBL] [Abstract][Full Text] [Related]
80. Efficacy and Safety of Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Dixon C; Cedano ER; Pacik D; Vit V; Varga G; Wagrell L; Tornblom M; Mynderse L; Larson T
Urology; 2015 Nov; 86(5):1042-7. PubMed ID: 26216644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
